Selection of phase II/III breast cancer study highlights at the 2022 ESMO annual meeting

IF 0.4 Q4 ONCOLOGY

memo - Magazine of European Medical Oncology Pub Date : 2023-04-20 DOI:10.1007/s12254-023-00891-4

M. Marhold

引用次数: 0

查看原文本刊更多论文

2022年ESMO年会选择II/III期乳腺癌研究重点

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

memo - Magazine of European Medical Oncology ONCOLOGY-

CiteScore

1.80

自引率

16.70%

发文量

期刊介绍： memo is the Official Journal of the Central European Cooperative Oncology Group (CECOG) and The Austrian Society of Haematology and Oncology (OeGHO). The focus of the journal "magazine of european medical oncology – memo" is to offer a professional review on current research and development in the field of hematology and oncology relevant for daily practice. Therefore, memo includes editorials and comments, peer-reviewed original reports, short reviews, case reports and controversies, articles explaining the biology of neoplasia and congress reports including qualified comments. As a European journal memo aims at highlighting the local peculiarities of various regions and at being a forum for the presentation of ongoing clinical and basic research.